Clinical Trials
2 trialsNCT03654105 2026-03-27
SMILE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Active not recruiting
NCT03532698 2020-07-23
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Unknown